GSO ASTM E734:2021

ASTM E734:80(2015)
Gulf Standard   Current Edition · Approved on 01 July 2021

Standard Specification for Disposable Glass Blood Sample Capillary Tube (Microhematocrit)

GSO ASTM E734:2021 Files

English 3 Pages
Current Edition Reference Language

GSO ASTM E734:2021 Scope

This specification describes the physical requirements and corresponding test methods for disposable glass blood sample capillary tubes for use in microhematocrit procedures. Covered here are two different types of capillary tubes, namely, Type I (coated with heparin), and Type II (uncoated). The tubes shall be fabricated from Type I, Class B borosilicate glass, or Type II soda lime glass. Conversely, the heparin used for coating Type I tubes shall be of ammonium salt isolated from the lungs or intestinal mucosa of beef or pork origin. The tubes shall conform to specified requirements for design, dimension, workmanship, color coding, and lot or control number. They should also pass the following tests for capillarity, fluidity, sheep plasma, positive and negative controls, human whole blood, heparin potency assay, and resistance to centrifugal force.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
BH GSO 2017:2023
GSO 2017:2023 
Bahraini Standard
Personal Care and Baby Wet Wipes
BH GSO 2241:2023
GSO 2241:2023 
Bahraini Standard
Cosmetic Products - Body Cleaners
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners

Recently Published from Health Sector

GSO EN 14988:2017+A2:2025
EN 14988:2017+A2:2024 
Gulf Standard
Children's high chairs - Requirements and test methods
GSO ISO 25649-4:2025
ISO 25649-4:2024 
Gulf Standard
Floating leisure articles for use on and in the water — Part 4: Additional specific safety requirements and test methods for Class B devices
GSO ASTM F1004:2025
ASTM F1004:23 
Gulf Standard
Standard Consumer Safety Specification for Expansion Gates and Expandable Enclosures
GSO ISO 18562-3:2025
ISO 18562-3:2024 
Gulf Standard
Biocompatibility evaluation of breathing gas pathways in healthcare applications — Part 3: Tests for emissions of volatile organic substances